Failure of High-Dose Ergocalciferol to Correct Vitamin D Deficiency in Adults with Cystic Fibrosis
- 15 July 2005
- journal article
- clinical trial
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 172 (2), 212-217
- https://doi.org/10.1164/rccm.200403-387oc
Abstract
Treatment guidelines for vitamin D monitoring and supplementation in cystic fibrosis (CF) have recently been developed and published by a consensus committee, but have not been prospectively tested. To use these guidelines to determine the percentage of adults with CF requiring vitamin D repletion therapy and to evaluate the effectiveness of the currently recommended high-dose oral ergocalciferol repletion protocol. Prospective study of clinical outcomes after therapy with the recommended vitamin D repletion algorithm. Of 134 adults with CF, 109 (81.3%) were found to have 25-hydroxyvitamin D (25-OHD) levels below the recommended 30 ng/ml. Sixty-six of these adults completed the recommended course of 400,000 IU of oral ergocalciferol over 2 months, and only five (8%) responded with correction of their serum 25-OHD to the goal of 30 ng/ml or greater (mean change, +0.3 ng/ml; from 18.8 to 19.1 ng/ml). In the 33 adults with CF who also completed the recommended second course of 800,000 IU of ergocalciferol over 2 months, none demonstrated correction of their deficiency (mean change, -1.2 ng/ml). The results of this study demonstrate that a majority of adults with CF have serum 25-OHD levels below 30 ng/ml, and the currently recommended ergocalciferol repletion regimen often does not fully correct vitamin D deficiency and may need to be revised to include even higher dosing of ergocalciferol. Further work is needed to establish the ideal 25-OHD level for maximizing calcium absorption and bone health in CF.Keywords
This publication has 34 references indexed in Scilit:
- Management of Osteoporosis in Adults with Cystic FibrosisDrugs, 2004
- Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular healthCurrent Opinion in Endocrinology, Diabetes and Obesity, 2002
- Bone Mineral Density Increases with Vitamin D Repletion in Patients with Coexistent Vitamin D Insufficiency and Primary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 2000
- Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factorsThorax, 2000
- Low bone mineral density in adults with cystic fibrosisThorax, 1999
- Resolution of Vitamin D Insufficiency in Osteopenic Patients Results in Rapid Recovery of Bone Mineral DensityJournal of Clinical Endocrinology & Metabolism, 1999
- Bone mineral density and body composition in adult patients with cystic fibrosis.Thorax, 1993
- Bone disease in chronic childhood cholestasis. I. vitamin D absorption and metabolism†Hepatology, 1989
- Bile Acid Malabsorption in Cystic Fibrosis With and Without Pancreatic InsufficiencyJournal of Pediatric Gastroenterology and Nutrition, 1984
- Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.Gut, 1979